Disruption of Radiological Surveillance Following a Global Health Crisis in Resected Lung Cancer
- PMID: 41806165
- PMCID: PMC12974329
- DOI: 10.1111/1759-7714.70264
Disruption of Radiological Surveillance Following a Global Health Crisis in Resected Lung Cancer
Abstract
Objectives: Radiological surveillance after curative-intent lung cancer resection is essential for early detection of recurrence and second primary tumors. Large-scale health emergencies can compromise oncologic follow-up. This study quantifies the impact of a health crisis on radiological surveillance in a national cohort of resected lung cancer patients.
Methods: A time-segmented observational cohort study was performed using data from the prospective, multicenter GEVATS registry. Surveillance density (CT/month) was evaluated across three predefined periods: pre-pandemic (baseline), state of alarm (maximum healthcare restrictions), and post-alarm (recovery phase). The population at risk was updated for each period. Subgroup analyses during the post-alarm phase assessed prioritization according to neoadjuvant treatment, pathological stage, age, and comorbidity.
Results: Among 2382 eligible patients, surveillance density declined progressively from the pre-pandemic period (0.157 ± 0.079 CT/month) to the state of alarm (0.098 ± 0.071 CT/month). In the post-alarm phase, density dropped sharply to 0.023 ± 0.018 CT/month (equivalent to one CT every 3.6 years), representing a 76.5% reduction compared with the state-of-alarm period (p < 0.001). This under-surveillance was generalized, with no significant differences by pathological stage (p = 0.084), age (p = 0.564), or comorbidity (p = 0.872). Only prior neoadjuvant therapy was associated with a slightly higher density (p = 0.040).
Conclusions: A prolonged health crisis resulted in a profound and persistent reduction in radiological surveillance after lung cancer resection, without evidence of risk-based prioritization. These findings support the need for contingency frameworks within clinical guidelines to preserve continuity of oncologic follow-up during future health emergencies.
Keywords: follow‐up studies; health services; lung neoplasms; thoracic surgery.
© 2026 The Author(s). Thoracic Cancer published by John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Philip B., Jain A., Ramesh P., et al., “Follow‐Up and Surveillance Post Lung Cancer Surgery: A Narrative Review,” Video‐Assisted Thoracic Surgery 8 (2023): 7, 10.21037/vats-22-28. - DOI
-
- Colt H. G., Murgu S. D., Korst R. J., Slatore C. G., Unger M., and Quadrelli S., “Follow‐Up and Surveillance of the Patient With Lung Cancer After Curative‐Intent Therapy: Diagnosis and Management of Lung Cancer, 3rd Ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines,” Chest 143, no. Suppl 5 (2013): e437S–e454S, 10.1378/chest.12-2365. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
